Exo Therapeutics Appoints Stephanos Ioannidis as Executive Vice President, Drug Discovery and Catherine Scholz as Senior Vice President, Program Management - read this article along with other careers information, tips and advice on BioSpace
19.04.2022 - Biotech executive with robust experience in financial and corporate strategy and operational excellence will strengthen the company’s leadership teamLONDON, April 19, 2022 (GLOBE NEWSWIRE) - Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the . Seite 1